Global, regional and national burden of low back pain 1990-2019: A systematic analysis of the Global Burden of Disease study 2019.
Global, regional and national burden of low back pain 1990-2019: A systematic analysis of the Global Burden of Disease study 2019.
复制标题
1990-2019 年全球、区域和国家腰痛负担:2019 年全球疾病负担研究的系统分析
DOI:
10.1016/j.jot.2021.07.005
复制
发表时间:
2022-01
影响因子:
6.6
通讯作者:
Xiao G
中科院分区:
文献类型:
--
作者:
Chen S;Chen M;Wu X;Lin S;Tao C;Cao H;Shao Z;Xiao G
To comprehensively analyze the global level and trends of prevalence, incidence and years lived with disability (YLDs) for low back pain (LBP) from 1990 to 2019 by age, sex and sociodemographic index (SDI). Publicly available modelled data and methods were obtained from the Global Burden of Diseases (GBD) study 2019, and used to evaluate the global burden of LBP through a systematic analysis. Globally, the age-standardized prevalence, incidence and YLDs rate of LBP were slightly decreased from 1990 to 2019, but the number of the prevalent cases, incident cases and YLDs had substantially increased, and LBP remains the leading cause of YLDs in 2019 worldwide. The number of prevalent cases was increased with age and peaked at the age of 45–54 years for both sexes, and the global prevalence rate was higher in females than in males and increased with age, peaking at the 80–84 age group in both sexes in 2019. Overall, a positive association between the age-standardized YLD rate and SDI was observed over the past thirty years. At the national revel, the United States, Denmark and Switzerland had the three highest levels of age-standardized prevalence, while Zambia, Zimbabwe and Canada showed the highest increase in the age-standardized prevalence during 1990–2019. LBP is a major public health issue globally, and its burden remains high. Increasing population awareness about its risk factors and preventive measures for LBP are needed to reduce the future burden of this condition. Due to the high prevalence and heavy burden of LBP globally, it is important to update its epidemiological data. This systematic analysis provides researchers and healthcare policy makers with up-to-date, comprehensive and comparable information on global LBP burden, which is of clinical translational significance.
登录
查看更多内容
影响因子:
3.3
作者:
de David CN;Deligne LMC;da Silva RS;Malta DC;Duncan BB;Passos VMA;Cousin E
通讯作者:
Cousin E
DOI:
10.1016/j.rdc.2016.12.011
发表时间:
2017-05
期刊:
Rheumatic diseases clinics of North America
影响因子:
--
作者:
Talsania M;Scofield RH
通讯作者:
Scofield RH
DOI:
10.1016/s0140-6736(18)32335-3
发表时间:
2018-11-10
期刊:
Lancet (London, England)
影响因子:
--
作者:
GBD 2017 DALYs and HALE Collaborators
通讯作者:
GBD 2017 DALYs and HALE Collaborators
影响因子:
120.7
作者:
Dieleman, Joseph L.;Cao, Jackie;Murray, Christopher J. L.
通讯作者:
Murray, Christopher J. L.
影响因子:
--
作者:
Wu, Aimin;March, Lyn;Hoy, Damian
通讯作者:
Hoy, Damian